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Abstract. The individualization of dialysis treatment using a customized dialysate composition usually requires
a continuous measurement of electrolytes and urea in blood. The current practices are spot measurements of
blood samples either with blood gas analyzers or in the laboratory, involving considerable personnel effort. Fur-
thermore, the measured values are time delayed and not available in a continuous fashion. In this paper we
investigate an in-line concept for continuous monitoring of important blood parameters such as sodium, potas-
sium, calcium and urea concentrations in blood serum using ion-selective electrodes. This concept is evaluated
in a preclinical study with human packed red blood cells as a test medium over a period of 7 h. It has been shown
that the electrolytes can be well monitored. In addition, we present first measurements with ion-sensitive field-
effect transistors in a miniaturized sensor assembly. Therefore, new low-cost electronics for such ion-sensitive
field-effect transistors have been developed.
1 Introduction
The individualization of dialysis treatment is receiving in-
creasing attention in research as critically ill patients in in-
tensive care units (ICUs) with acute kidney injury (AKI) par-
ticularly benefit from it (Palmer, 2001; Locatelli et al., 2015;
Sharma et al., 2016; Kovesdy et al., 2007; Paula et al., 2004;
Stiller et al., 2001).
AKI is the rapid loss of renal function, usually diag-
nosed by the accumulation of end products of the nitrogen
metabolism, such as urea nitrogen and creatinine, in conjunc-
tion with reduced urinary excretion (Bellomo et al., 2012).
In particular, critically ill patients in ICUs who suffer from
multiorgan failure or sepsis often develop AKI (Zarjou and
Agarwal, 2011; Baue et al., 2000; Bagshaw et al., 2008).
Such patients show mortality rates of 50 %–60 % (Ricci et al.,
2006; Palmer, 2001). Critically ill patients with AKI usually
receive continuous renal replacement therapy (CRRT) treat-
ments (Patel et al., 2010; Patschan and Müller, 2015; Ricci
et al., 2006; Tumlin et al., 2008). The major difference be-
tween CRRT and the regular intermittent dialysis applied to
chronic kidney diseases is the duration of the treatment and
the rate at which water and waste products are removed from
the extracorporeal circuit via diffusion across the semiper-
meable membrane of the dialyzer (Patel et al., 2010). While
intermittent dialysis aims at the maximum clearance of waste
products and the normalization of electrolytes at a treatment
with a duration of 3–4 h, CRRT focuses on a significantly
slower normalization of blood parameters over a treatment
duration of several days, which is beneficial for critically ill
patients as a rapid change in osmotic substances can lead to
different complications (Patel et al., 2010; Sivalingam and
Farrington, 2007; Stiller et al., 2001).
For example, a rapid change in the sodium plasma con-
centration, and thus an abrupt shift in plasma osmolarity, can
cause cardiovascular instability, overhydrating of cells and
disequilibrium syndrome with muscle cramps, fatigue symp-
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toms and headaches. However, insufficient sodium removal
and hence sodium accumulation can lead to increased thirst,
hypertension and pulmonary edema (Stiller et al., 2001;
Palmer, 2001; Locatelli et al., 2015; Paula et al., 2004).
Although other approaches exist for determining the
sodium concentration by conductivity measurements, and
some of these approaches even work in a contactless manner,
other electrolytes cannot be determined this way (Stragier et
al., 2018; Tura et al., 2013; Berger et al., 2019b, 2020). In
particular, potassium is another important parameter as a fre-
quent complication of AKI is hyperkalemia, known as a trig-
ger for heart arrhythmia. The same applies to hypokalemia.
However, not only the absolute concentration of potassium
is important. In Buemi et al. (2005) and Palmer (2001), it is
shown that an abrupt change in the potassium concentration
can trigger such arrhythmias as well because it induces a crit-
ical ratio between the intracellular and extracellular potas-
sium concentration. Therefore, Redaelli et al. (1996) recom-
mend a maximum difference in the potassium concentration
of 1.5 mmol L−1 between the dialysate and the blood, with
an exponential profile of the dialysate concentration to limit
the diffusion and thus to limit the change in potassium con-
centration in the blood. In order to adjust this required con-
centration gradient and to achieve the desired plasma con-
centration profile for potassium and sodium, it is necessary
to continuously monitor the plasma concentration.
Ionized (free) calcium is another important parameter in
extracorporeal circuits, since it is essential for blood coag-
ulation. Especially in CRRT, anticoagulation is necessary
to avoid clotting inside the dialyzer over the long period
of treatment. As critically ill patients may also have an in-
creased risk of bleeding, a global anticoagulation using, for
example, heparin, which is currently the most commonly
used extracorporeal anticoagulant, has to be avoided. In con-
trast to heparin, citrate can be used as a regional anticoag-
ulant. Therefore, citrate is added to the blood inside the ex-
tracorporeal circuit before the blood passes through the dia-
lyzer, binding the ionized calcium into a complex and thus
preventing blood coagulation. After passing the dialyzer and
before the blood is returned to the patient, additional ionized
calcium is added to the extracorporeal circuit to reactivate
coagulation (Davenport and Tolwani, 2009). In order to con-
trol the exact amount of citrate being added, it is necessary to
continuously measure the ionized calcium concentration as it
is the measure for blood coagulation.
Furthermore, an important marker representing the effi-
ciency of a dialysis treatment is the urea reduction ratio
(URR), according to Eq. (1), as urea represents all waste





Here, cpre is the predialysis urea concentration in blood and
cpost is the blood urea concentration after the dialysis treat-
ment. URRs of less than 60 % are associated with a higher
Figure 1. Schematic depiction of the in-line measuring concept
with ion-selective electrodes placed in a sensor compartment sepa-
rated from the blood in the extracorporeal circuit by a dialysis mem-
brane. The sensor compartment also enables calibration of the ion-
selective electrodes just before usage by simply flushing the sensor
compartment with a calibration solution. Furthermore, cyclical re-
calibration is possible for long-term measurements to improve ac-
curacy.
mortality in patients during dialysis (Owen et al., 1993).
However, using Eq. (1), the efficiency can only be deter-
mined after the treatment. Thus, it is also beneficial to con-
tinuously monitor the blood urea concentration in order to
evaluate the efficiency of dialysis treatment in line and in real
time.
The current practice for determining blood parameters is
to analyze blood samples in the laboratory or use a blood
gas analyzer. This way, monitoring requires a considerable
amount of personnel effort and high costs. Moreover, the re-
sults are time delayed and not available in a continuous fash-
ion.
2 Concept – continuous in-line monitoring of
electrolytes and urea
In Berger and Zimmermann (2017) and Berger et al. (2019a)
we introduced a simple concept for the continuous in-line
monitoring of electrolyte and urea concentrations in extracor-
poreal circuits, enabling an individualized dialysis treatment
using ion-selective electrodes (ISEs). As shown in Fig. 1, this
concept is based on separating the blood in the extracorpo-
real circuit from the sensor compartment containing the ISEs
with a dialysis membrane.
The membrane allows the exchange of all relevant sub-
stances, such as electrolytes and urea, between the sensor
compartment and blood, while retaining, for example, pro-
teins which can adsorb on the sensor surface, causing a sen-
sor drift (Sharma et al., 2016) or blood coagulation. Since
substance transport between the blood and sensor compart-
ment is based on diffusion, a certain time is required to reach
a concentration equilibrium between the blood in the extra-
corporeal circuit and the fluid in the sensor compartment. A
detailed investigation of the sensor response dynamics and
the resulting errors related to this measurement concept is
shown in Berger et al. (2018). For higher accuracy, sensor
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Figure 2. Photograph of the in-line measuring chamber for contin-
uous monitoring of blood parameters in extracorporeal circuits.
calibration just before usage is possible by simply flushing
the sensor compartment with two different calibration solu-
tions in sequence. This also allows for cyclical recalibration
because the sensor compartment can be flushed with a phys-
iological solution of known concentrations at certain inter-
vals, which is especially useful for longer treatments. Such
in-line offset adjustments significantly improve the accuracy
of potentiometric measurements and are especially useful for
compensating for any temporal sensor drift. Figure 2 shows
a photograph of the measuring chamber used that consists of
two parts made of polyether ether ketone (PEEK). The up-
per part contains the ISEs and has two Luer connectors to fill
in the calibration solutions. The calcium and potassium elec-
trode was purchased from AMEL S.r.l. The sodium electrode
was purchased from Metrohm. As a reference electrode, we
used an Ag/AgCl electrode (Mettler-Toledo GmbH). The
lower part also has two Luer connectors, enabling a simple
integration into the extracorporeal circuit. The semiperme-
able dialysis membrane is located between the two PEEK
parts. The measuring chamber was developed and manufac-
tured, and particularly designed to achieve hemocompatible
blood flow, in cooperation with InnoMe GmbH (Espelkamp,
Germany) and Barkey GmbH & Co. KG (Leopoldshöhe,
Germany).
In this work, we present the first measurements using this
concept in an extracorporeal circuit with human packed red
blood cells (PRBCs) as a test medium to simulate realistic
conditions. Moreover, we propose miniaturizing the sensor
compartment by using ion-sensitive field-effect transistors
(ISFETs). This includes the development of low-cost elec-
tronics to drive the ISFETs.
3 Concept – urea sensor
To measure the urea concentration, we used a biosensor con-
sisting of an ammonium ISE (AMEL S.r.l.) and the enzyme
Figure 3. Schematic cross section of the urea sensor, consisting of
an ammonium ISE with an additional 0.5 mm spacer, and a dialysis
membrane that forms the enzyme compartment.
urease. Using urease, the urea is catalyzed into ammonium
and carbonate ions according to Eq. (2), and the ammonium







Different approaches exist to immobilize the enzyme near
the electrode; for example, the cross-linking of the enzymes
(Singh et al., 2008). However, such an approach often uses
toxic chemicals, making an in-line measurement according
to our concept difficult. Moreover, the activity of the en-
zyme is often reduced. Therefore, we used a simple method
for immobilization consisting of a dialysis membrane (RCT
NatureFlex-NP; Reichelt Chemietechnik) with a molecular
weight cutoff of 10–20 kDa to retain the enzyme solution
inside a small enzyme compartment created by a 0.5 mm
spacer, which is bonded to the ISEs as depicted in Fig. 3.
The bonding of the 0.5 mm spacer to the ISEs was realized
in cooperation with InnoMe GmbH (Espelkamp, Germany).
Since urea has a molecular weight of about 60 Da, it can
diffuse into the enzyme compartment. However, urease can-
not pass the membrane and is retained inside this compart-
ment as its molecular weight is 480 kDa. Thus, the ammo-
nium ions are generated near the sensitive layer of the am-
monium ISE at full enzyme activity. The urea sensor was in-
tegrated into the sensor compartment of the measuring cham-
ber together with the ISEs for the electrolytes.
4 Experiment – preclinical investigation
In order to simulate an extracorporeal circuit under realis-
tic conditions, we used a test bench set up at the University
Medical Center Göttingen containing the multiFiltrate dial-
ysis system and the AV 600S Ultraflux dialyzer (both from
Fresenius Medical Care), as depicted in Fig. 4.
Using the peristaltic pump of the dialysis system, the
PRBCs are pumped from the blood bag through a three-port
valve, an air trap and then the dialyzer at a flow rate of about
100 mL min−1, representing a typical flow rate in CRRT. The
in-line measurement system is integrated into this simulated
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Figure 4. Schematic depiction of the test bench using human
packed red blood cells as a test medium. Blood samples are drawn
at regular intervals via the three-port valve and are then analyzed
by a standard blood gas analyzer (BGA) and in the laboratory. The
BGA values serve as a reference for the ion-selective electrodes to
determine the electrolyte concentration, and the laboratory values
serve as a reference for the urea sensor.
extracorporeal circuit. The three-port valve enables one to
draw blood samples, which are taken approximately every
10 min, for analysis in a GEM Premier 4000 (Instrumentation
Laboratory) blood gas analyzer (BGA) and to also draw sam-
ples for analysis in the laboratory every 20 min. The blood
gas analyzer is used as a reference for the electrolyte con-
centrations, and the laboratory analysis as a reference for
the urea concentration. It should be noted that, according to
Bénéteau-Burnat et al. (2008), the GEM Premier 4000 has a
standard deviation coefficient (CV) of 1 % for sodium, 1.5 %
for potassium and 1.2 % for calcium. On the other side of the
filter membrane of the dialyzer, fresh dialysate is pumped
into the dialyzer, and the spent dialysate is pumped into a
waste bag.
The electrolyte and urea concentrations in the fresh
dialysate were varied for test purposes over the duration
of the experiment. Diffusion between the dialysate and the
blood caused a continuous change in the concentrations in
the blood, resulting in a maximum change of 50 (113 to
163 mmol L−1) for sodium, 8.8 (1.9 to 10.7 mmol L−1) for
potassium, 1.695 (0.095 to 1.790 mmol L−1) for calcium and
178.2 (1.8 to 180 mg dL−1) for blood urea nitrogen (BUN),
all covering the clinical relevant concentration ranges.
4.1 Results – electrolyte monitoring
To experimentally investigate the in-line measuring concept,
we changed the concentration of all blood parameters of in-
terest (namely sodium, potassium, calcium and urea) simul-
taneously, as described above, via the dialysate concentration
within the clinically relevant range. The ISEs were calibrated
just before the measurement term by filling the sensor com-
partment with two defined calibration solutions according to
Figure 5. Continuously measured sodium concentration using the
calibrated ISEs (solid blue line) compared to the blood gas analyzer
(BGA) as a reference (red circles).
(Cammann, 1979; Osswald and Wuhrmann, 1981; Cammann
and Galster, 1996). The two calibration solutions we use have
different electrolyte concentrations, namely c0 and c1, of the
individual electrolytes but have the same ionic strength of
160 mmol L−1 in total, which compares to the blood ionic
strength, enabling a so-called concentration calibration in
which the output voltage of the respective electrodes versus
an Ag/AgCl reference electrode is approximately propor-
tional to the concentration in a certain concentration range
and not only to the activity of the ions. With the calibra-
tion, the sensitivities S of the sodium, potassium and calcium
ISEs as well as the voltage U0 between the ISEs versus the
Ag/AgCl reference electrode for a known concentration c0
can be determined. Table 1 summarizes these values.
Using the parameters in Table 1 and the voltage UISE
recorded between the ISEs versus the reference electrode
during the experiment, the concentration c can be calculated,
according to Eq. (3), as follows:
c = c0 · 10
(UISE−U0)
S . (3)
Figure 5 shows the results for the sodium concentration over
a period of 7 h. The circles depict the blood samples analyzed
by the blood gas analyzer as a reference. The solid curve is
the output signal of the calibrated ISEs. It can be seen that
the measured sensor signal and the reference signal correlate
very well, and there are just small deviations at about 3 and
6 h. This is due to the dynamic behavior of the measurement
concept, as shown in Berger et al. (2018). However, the blood
concentration was changed very fast for test purposes, which
is much higher than physiological rates.
For the potassium concentration, depicted in Fig. 6, there
is a deviation between the sensor and the reference at the be-
ginning of the measurement since the calibration solution is
still in the sensor compartment when the system is integrated
into the extracorporeal circuit, and in this case it has a differ-
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Table 1. Parameters of the ISEs obtained by the calibration.
Sodium ISE Potassium ISE Calcium ISE
Calibration solution c0 in mmol L−1 155 2.6 0.8
Calibration solution c1 in mmol L−1 125 17 6
Sensitivity S in mV per concentration decade 60.06 54.74 23.30
Voltage U0 in mV at concentration c0 93.10 426.20 411.80
Figure 6. Continuously measured potassium concentration using
the calibrated ISEs (solid blue line) compared to the blood gas ana-
lyzer as a reference (red circles).
ent initial electrolyte concentration compared to blood. Thus,
a certain time is required until the concentration equilibration
between the blood and the sensor compartment is reached.
After this initial mismatch, the sensor signal and the refer-
ence signal agree in good approximation for most of the time
after the initial mismatch.
As shown in Fig. 7, the reference and the measurement sig-
nal agree well, with the exception of the time between hour
5 and 6 where a small deviation of about 0.25 mmol L−1 can
be observed. This also applies for the very low concentration
after 6 h, which is particularly interesting for citrate antico-
agulation. The reason for the mismatch from hour 5 to 6 is
unknown.
All the results show that the electrolyte concentrations
can be measured in good agreement with the reference sys-
tem. No relevant sensor drift or cross-sensitivity was ob-
served during the experiment, as was expected, for the
given cross-sensitivity coefficients for the calcium ISE to
sodium of KCa,Na<1× 10−6 (mol L−1)−1 and to potas-
sium of KCa,K = 1.45× 10−4 (mol L−1)−1, potassium ISE
to sodium of KK,Na = 2.6× 10−3 and to calcium KK,Ca =
2.5× 10−3 (mol L−1)−1/2, and sodium ISE to potassium of
KNa,K = 3.9×10−3 and to calcium ofKNa,Ca = 2.67×10−6
(mol L−1)−1/2.
Figure 7. Continuously measured calcium concentration using the
calibrated ISEs (solid blue line) compared to the blood gas analyzer
as a reference (red circles).
4.2 Results – urea monitoring
The first experiments concentrated on the time delay between
the sensor signal and the urea concentration caused by the
additional diffusion length and membrane used for enzyme
immobilization. Figure 8 shows a significant time delay of
about 20–30 min. Furthermore, a drift in the sensor signal
can be observed. One possible reason could be the loss of
the enzyme urease from the enzyme compartment due to a
damaged membrane. At least the urea concentration trend is
visible, but future work needs to concentrate on improving
the urea sensor construction to reduce this time delay and
allow for a calibration just before the usage and quantitative
measurements.
5 ISFETs for miniaturization
As shown by the preclinical investigations above, the concept
of electrochemical sensors is suited for continuous monitor-
ing of electrolyte concentrations in extracorporeal circuits.
However, using standard ion-selective electrodes makes the
measuring chamber difficult to handle and cost intensive as
the electrodes are quite large and expensive. Therefore, we
tried to replace the ISEs with ISFETs. However, we will just
show the preliminary data and present this section as an out-
look on miniaturization, with a focus on newly developed
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Figure 8. Continuously measured urea concentration using the am-
monium ISE (solid blue line) compared to the laboratory analysis
(red circles).
electronics for driving several ISFETs with one reference
electrode.
An ISFET has the same basic structure as a common metal
oxide semiconductor field-effect transistor (MOSFET) with
a source pin S and a drain pin D, but the metal gate is re-
placed by an ion-selective membrane used for measuring the
ion concentration in a liquid solution (Bergveld, 2003a, b).
The linear mode, also known as ohmic mode, of the ISFET
is characterized by the linear dependence of the drain cur-
rent ID on the gate-source voltage UGS and can be described








Here β is a geometric constant that depends on the ISFET
manufacturing process.UGS can be considered to be the volt-
age between the reference electrode and the source potential
of the ISFET, and UDS is the drain-source voltage across the
ISFET.UTH is the threshold voltage at which a current ID be-
gins to flow through the transistor. The linear mode is valid
as long as the condition UDS< (UGS−UTH) is true.
As mentioned earlier, potentiometric measurements can
be used to determine the concentration c if the concentra-
tion range of the target ion being investigated is limited and,
thus, the ionic strength does not vary significantly (Cam-
mann, 1979; Osswald and Wuhrmann, 1981; Cammann and
Galster, 1996). This can be assumed to be valid for blood as a
test medium. Incidentally, this is the reason why a commer-
cially available blood gas analyzer works in a limited con-
centration range and the concentrations can be determined
potentiometrically. Therefore, in the following equations the
activity a is replaced by the concentration c, even if this is
not fully correct but still permissible.
If the concentration c changes inside the test solution, the
target molecules interacting with the ion-selective membrane
of the gate connection change in the threshold voltage UTH





Here, R is the gas constant, F is the Faraday constant, z is
the charge number and T is the absolute temperature. The
result is a change in the drain current, according to Eq. (4),
which is often used as a measure of the ion concentration.
Below, we show a simple low-cost electronic circuit which
controls both the drain current and the drain-source voltage
at a constant value.
There are numerous concepts for the readout circuits of IS-
FETs. However, some of these circuits have a disadvantage in
that multiple ISFETs cannot have a common reference elec-
trode, thus making a miniaturization impossible (Cruz et al.,
2018; Chung et al., 2004, 2006). Others have a disadvantage
in that they are difficult to realize with inexpensive discrete
components (Premanode et al., 2006; Cruz et al., 2018; Pre-
manode et al., 2007), the operation point is difficult to ad-
just (Cruz et al., 2018; Morgenshtein et al., 2004) or they are
subject to greater temperature or humidity effects (Chung et
al., 2006; Cruz et al., 2018; Premanode et al., 2006). Our ap-
proach controls the drain-source voltage and the drain current
at a constant value. This keeps the input power for the readout
constant, leading to a concentration-independent temperature
and therefore a constant temperature of the ISFETs. Since the
temperature of the blood in the extracorporeal circuit corre-
sponds to the body temperature, temperature effects are thus
limited to a minimum. In addition, the chosen circuit allows
the simultaneous readout of multiple ISFETs sharing a com-
mon reference electrode, enabling real miniaturization and
further cost reduction. Figure 9 shows the schematic of the
readout circuit for one ISFET. As an operational amplifier
(OP), we use the low-cost TL072 (Texas Instruments).
The current control of ID is realized by the opera-
tional amplifiers, namely OP1 and OP2, the MOSFET T1
(IRLML2502; Infineon Technologies AG), the resistor R2,
and the reference voltage source URef. For this purpose, URef
has a constant voltage of 3 V provided by the ADR443 (Ana-
log Devices, Inc.) and is connected to the noninverting input
of OP1. To obtain the current ID of 100 µA, R2 has a resis-
tance of 30 k. If the current IR2 is 100 µA, a voltage drop of
3 V across R2 is caused, which is fed back to the inverting in-
put of OP1. The output of OP1 controls T1 to keep the current
of IR2 constant. A smaller current IR2, for example, would
result in a smaller voltage drop over R2. Consequently, the
voltage at the noninverting input of OP1 would be higher
compared to the inverting input, leading to an increased out-
put voltage of OP1, thus further driving the MOSFET T1,
and resulting in an increased current IR2. In contrast, a higher
current would be decreased by reducing the output voltage of
OP1. As the input of OP1 and OP2 draws a maximum current
of 7 nA over the full temperature range of 0 to 70 ◦C (Texas
Instruments, 1978), the current ID through the ISFET, which
is the sum of IR2, IOP1 and IOP2, is a good approximation for
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Figure 9. Schematic of the ISFET readout circuit for one ISFET with TL072 OPs. In addition, the bias voltages UBias2 and UBias3 are shown
for the additional two independent readout circuits.
the controlled current IR2. Resistor R1 limits the output cur-
rent of OP1 required for charging the gate capacity of T1. To
obtain a constant voltage drop of UDS = 0.5 V from drain D
to source S across the ISFET, a voltage of 0.5 V is added to
the source voltage US by the summing amplifier, consisting
of resistor R3, R4 and R5 as well as OP4. The value for R3
and R5 is 10 k and R4 is 60 k. The output voltage of OP4

















=−(US+ 0.5V ). (6)
This voltage is amplified by the inverting amplifier, consist-
ing of OP5 and the resistors R6 and R7 by a factor of −1,
resulting in a drain potential of UD = US+ 0.5 V. The op-
erational amplifiers are supplied with U+ = 15 V and U− =
−15 V. The ground reference potential is not directly con-
nected to the potential of the reference electrode but is biased
by the voltage source UBias1 to ensure that the ISFET begins
to conduct even at low concentrations and always has a volt-
age drop of 3 V across R2, indicating a drain current ID of
100 µA.
By changing the concentration of the target electrolyte in
the liquid, the threshold voltage of the ISFET changes, lead-
ing to a change in ID. However, by controlling ID to 100 µA,
the source potential US of the ISFET has to be adjusted.
Thus, the source potential US depends on the ion concen-
tration in the liquid and can therefore be used as the output
signal UOut according to Nernst law. To not affect the cur-
rent ID with a voltage measurement, it is determined after
the buffer amplifier consisting of OP2.
In order to enable a simultaneous readout of all ISFETs for
sodium, potassium and calcium with one common reference
electrode, the described circuit is built up three times, which
is indicated in Fig. 9 by the blue boxes. As the different IS-
FETs have different threshold voltages, different gate-source
voltages UGS are required for each ISFET to meet the condi-
tions for the linear mode. Since UGS depends on the potential
of the reference electrode, it is necessary to set the potential
of this electrode independently for each circuit. Therefore,
the ground potentials (GND1 to GND3) of the three read-
out circuits are isolated from each other. As illustrated in
Fig. 9, three voltage sources, UBias1 to UBias3, are connected
in parallel to each other and to the reference electrode in or-
der to shift the respective isolated ground potential (GND1
to GND3) of the individual readout circuits. Due to UBias1 to
UBais3 and the insulated circuit design, these voltages can be
adjusted independently, even if one common reference elec-
trode is shared, enabling a compact design.
5.1 Preliminary results – ISFETs
In a preliminary investigation we tested the ISFETs pur-
chased from D+T Microelectrónica, A.I.E. In particular, the
sensitivity S and the cross-sensitivities of the sensors were
analyzed. Here, the cross-sensitivities of the potassium IS-
FET to sodium (KK,Na) and of the calcium ISFET to sodium
(KCa,Na) are relevant, since sodium has the highest absolute
concentration and, more importantly, the highest fluctuation
in blood serum. However, large cross-sensitivity coefficients
can also lead to high absolute errors – even for small concen-
tration variations.
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First, the sensitivity of each sensor was determined. There-
fore, we increased the concentration of the target ion for
the corresponding sensor in a sample solution at room tem-
perature, while the concentration of interfering ions was
kept constant. For the sodium sensor the sample solu-
tion contained 1 mmol L−1 calcium chloride (CaCl2) and
4 mmol L−1 potassium chloride (KCl) in deionized water.
The sample solution for the potassium sensor included a
constant concentration of 140 mmol L−1 sodium chloride
(NaCl) and 1 mmol L−1 CaCl2 in deionized water. Accord-
ingly, the sample solution for the calcium sensor contained
140 mmol L−1 NaCl and 4 mmol L−1 KCl in deionized wa-
ter. If the output voltage UOut is plotted against the common
logarithm of the concentration of the target ion, the slope
of the linear fit in the range of higher concentrations repre-
sents the sensitivity S in that concentration range. The sen-
sitivity SNa for sodium is 53.59 mV per decade (Fig. 10a)
and the sensitivity SK for potassium is 52.75 mV per decade
(Fig. 10b), with both slightly below the theoretical maximum
for monovalent ions of about 59.50 mV per decade at room
temperature according to the Nernst law. The calcium ISFET
(Fig. 10c) has a sensitivity of SCa = 26.91 mV per decade,
which is also slightly below the theoretical maximum for di-
valent ions of 29.75 mV per decade.
The cross-sensitivity of ion-selective sensors is described

















Here, U0 is the output voltage at concentration cT of
1 mol L−1 of the target ion with the charge number zT. cI is
the concentration of one interfering ion with the charge num-
ber zI. KT,I is the cross-sensitivity coefficient for the target
ion to the interfering ion I. It indicates by how many times the
interfering ion is suppressed in the sensor output compared
to the target ion.
According to the International Union of Pure and Applied
Chemistry’s (IUPAC) recommendations, the cross-sensitivity
can be determined in a similar way to the sensitivity, with the
difference being that a constant concentration of one single
interfering ion is present in the sample solution. Since the
cross-sensitivity is a function of the concentration cI of the
interfering ion, it is advisable to choose cI close to the ex-
pected concentration in the later application. Subsequently, a
calibration curve is recorded for the target ion. For very small
concentrations cT of the target ion it can be assumed thatUout
is mainly determined by the interfering ion, and thus Uout is
a constant. For higher concentrations of cT the target ion de-
termines the output voltage Uout, which can be approximated
with the linear fit of the slope S. At the point of intersection
for both extrapolated lines (comparable with Fig. 10), the two









= ln (cintersection) , (8)
where cintersection is the concentration at the point of intersec-
tion for both extrapolated lines. This yields Eq. (9) for the








KT,I was determined in this manner for the ISFETs for
sodium, potassium and calcium. The cross-sensitivity coef-
ficients are KCa,Na and KK,Na for the calcium sensor and
the potassium sensor affected by sodium, which were deter-
mined to beKCa,Na = 1.35×10−4 (mol L−1)−1 andKK,Na =
3.53× 10−4. Assuming a maximum physiological change in
the sodium concentration of 40 mmol L−1, this would re-
sult in an error of only 14.12 µmol L−1 for potassium and
0.22 µmol L−1 for calcium according to Eq. (7). Table 2 sum-
marizes all measured ISFETs parameters. As can be seen in
Table 2, the cross-sensitivity coefficient of the sodium ISFET
to potassium is the highest with 6.20× 10−2, leading to an
error of 0.25 mmol L−1 for a maximum possible potassium
concentration change of 4 mmol L−1.
One major issue of ISFETs is their limited long-term sta-
bility, a fact that still prevents their commercial use until to-
day (van der Schoot et al., 1983; Jamasb et al., 1998; Jamasb,
2004; Chou and Hsiao, 2000). The ISFETs used here also
show such a drift. In particular, at the beginning of a mea-
surement the drift can be very high. To illustrate this, we have
placed the ISFETs for the three electrolytes in a physiolog-
ical solution consisting of 140 mmol L−1 NaCl, 4 mmol L−1
KCl and 1 mmol L−1 CaCl2 in deionized water over a period
of more than 4 h and recorded the output voltage UOut. The
results are depicted in Fig. 11.
Figure 11 illustrates that the output voltage of the ISFETs
is subject to a temporal drift in which the potassium IS-
FET significantly drifts at the beginning of the measurement.
However, in the proposed in-line measuring concept, the IS-
FETs could be easily and periodically recalibrated to com-
pensate for such a drift. This approach will be investigated in
future work, including a preclinical investigation with human
packed red blood cells as a test medium.
6 Conclusion
In this work, we have investigated a new concept for the con-
tinuous in-line monitoring of electrolyte and urea concentra-
tions under realistic conditions in a preclinical study using
human packed red blood cells as a test medium in an ex-
tracorporeal circuit. It is shown that the measured sodium,
potassium and calcium concentrations agree very well with
the blood gas analyzer values used as a reference system. No
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Figure 10. Calibration curve of the sodium ISFET (a), potassium ISFET (b) and calcium ISFET (c) with linear regressions for high concen-
trations to calculate the sensitivities. The concentration c is given in mol L−1.
Table 2. Characterized parameters of sodium, potassium and calcium ISFETs.
Sodium ISFET Potassium ISFET Calcium ISFET
Sensitivity S in mV per decade 53.59 52.75 26.91
Cross-sensitivity KT,Na (sodium as interfering ion) – 3.53× 10−4 1.35× 10−4 (mol L−1)−1
Cross-sensitivity KT,K (potassium as interfering ion) 6.20× 10−2 – 2.04× 10−2 (mol L−1)−1
Cross-sensitivity KT,Ca (calcium as interfering ion) 5.00× 10−3 (mol L−1)1/2 4.23× 10−4 (mol L−1)1/2 –
Figure 11. Long-term stability measurement of the sodium ISFET
(blue), potassium ISFET (red) and calcium ISFET (black) in deion-
ized water with constant concentration of 140 mmol L−1 of sodium
chloride, 4 mmol L−1 of potassium chloride and 1 mmol L−1 of cal-
cium chloride over a period of about 4 h.
relevant sensor drift or cross-sensitivities were observed over
a test duration of 7 h. The urea sensor, consisting of an am-
monium ISE and the enzyme urease, immobilized with an ad-
ditional dialysis membrane attached to the ammonium ISE,
showed a significant time delay in the sensor signal due to
the additional membrane and the increased diffusion length.
Furthermore, a sensor drift could be observed, which was
probably caused by a damaged membrane used for enzyme
immobilization.
As we move towards miniaturization, we have tried ion-
sensitive field-effect transistors (ISFETs) purchased from
D+T Microelectrónica, A.I.E. instead of using large and
expensive standard ISEs. Therefore, low-cost electronics
were developed, enabling all ISFETs to be read out to-
gether, sharing a common reference electrode. In addi-
tion, the ISFETs were characterized regarding their sen-
sitivity, cross-sensitivity and temporal drift. As expected,
the sensitivity is close to the Nernst sensitivity. With re-
spect to cross-sensitivities, the interferences between the cal-
cium ISFET and potassium ISFET in relation to sodium
described by KCa,Na and KK,Na are particularly impor-
tant, since the fluctuation of sodium is the most signifi-
cant. However, even a change in the sodium concentration
of 40 mmol L−1 just causes an error of 0.22 µmol L−1 for
calcium and 14.12 µmol L−1 for potassium due to the small
cross-sensitivity coefficients. A crucial disadvantage of IS-
FETs is the temporal drift. The sensors used in this study are
also subject to such a drift. However, the measurement con-
cept presented in this work allows for a cyclical recalibration
of the ISFETs. The concept of cyclical recalibration needs to
be further investigated in future work. In summary, the pre-
sented measuring concept using ISEs is suitable for the con-
tinuous monitoring of sodium, potassium and calcium. For
urea, a significant time delay caused by the urea sensor con-
cept is present, leaving much room for improvement. In prin-
ciple, the ISFETs can be used for miniaturization. However,
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to assess the ISFETs under practical conditions another pre-
clinical investigation with a miniaturized setup is necessary
in future work.
To conclude, the presented in-line measuring system could
be a considerable advancement compared to the current gold
standard of a few spot measurements with a time-delayed re-
sponse due to laboratory analysis. Furthermore, personnel ef-
fort would be significantly reduced. In general, the continu-
ous measurement of blood parameters is an important step
towards individualized dialysis, leading to a significant im-
provement in the patient’s treatment.
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